• search
Empowering Drug Innovation Worldwide Empowering Drug Innovation Worldwide

Empowering Drug Innovation Worldwide

Delivering end-to-end excellence in
drug discovery, development and manufacturing for small molecule and biologics

20+ years of legacy | 125+ global clients | Comprehensive service portfolio

With a robust global footprint, Aurigene Pharmaceutical Services is a trusted partner for pharmaceutical and biotech innovators worldwide. Our strategically located R&D centres and cGMP-certified manufacturing facilities across the continents enable us to deliver seamless, end-to-end drug discovery, development, and manufacturing services (CRDMO) for both small molecule and Biologics. As a wholly owned subsidiary of Dr. Reddy’s Laboratories, we are committed to sustainability, quality, and innovation, striving to make affordable and innovative medicines accessible globally.

In the discovery space, Aurigene boasts a legacy of more than 25 years of operations and has long-term partnerships with two of the top five pharmaceutical companies. We offer chemistry, biology, and integrated services across the life cycle of drug discovery, from target identification to IND filing. We operate in a flexible manner and offer our services in FTE and/or FFS mode; integrated and/or standalone mode.

Get in touch with our global representatives

Our global manufacturing footprint

Drug substance cGMP facilities

  • CTO-Mexico: Large-scale small molecule APIs, steroids and mPEG Alcohol
  • CTO-Mirfield: Small molecule, prostaglandin and mPEG derivatives
  • CTO-1, India: High potent and small molecule APIs
  • CTO-2, India: Small molecule APIs and Nutraceuticals
  • CTO-3, India: Low and medium scale small molecule APIs
  • CTO-5, India: Large-scale small molecule APIs
  • CTO-6, India: Small molecule, peptide, spray drying and high potent
  • CTO-SEZ, India: Small molecule, continuous manufacturing, spray drying and high potent

*CTO - Chemical Technical Operations

Drug product cGMP facilities

  • FTO-2: Regular OSDs (oral solid dosage forms)
  • FTO-3: Regular OSDs
  • FTO-7: Cyto parenterals and cyto and harmonal OSDs
  • FTO-9: Non- cyto parenterals ophthalmics and BFS
  • FTO-11: Parenterals cyto and non-cyto
  • FTO-PU1: Regular OSDs
  • FTO-PU2: Topicals, soft gelatin, and potent OSDs

*FTO - Formulation Technical Operations

×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack